Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort

  • Fernandez-Camins, Berta
  • Vlacho, Bogdan
  • Rojo-López, Marina Idalia
  • Granado-Casas, Minerva
  • Gratacòs, Mònica
  • Ortega-Bravo, Marta
  • Cendros-Massioui, Maria
  • Palmieri, Flavio|||0000-0002-1455-4923
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch-Nadal, Josep
  • Mauricio, Dídac
  • COPERNICAN Research Group, The
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03198-w., Background: Current diagnostic criteria for type 2 diabetes (T2D) capture disease heterogeneity poorly, and do not reliably predict progression, complications, or treatment response. The phenotypic clustering model proposed by Ahlqvist et al. identified five T2D subtypes using six clinical variables at diagnosis, each associated with distinct metabolic profiles and complication risks. Although this framework has been replicated in several cohorts, evidence in Mediterranean populations is lacking. Methods We conducted a prospective cohort study in Catalonia (Northeast Spain) including adults with newly diagnosed T2D recruited between March 2022 and January 2026. Using baseline data, we evaluated the Ahlqvist clustering approach. Autoantibody-positive individuals were classified as severe autoimmune diabetes (SAID), and sex-stratified k-means clustering (k = 4) was applied to autoantibody-negative participants. Cluster separation and stability were assessed using principal component analysis and silhouette analyses. Results A final total number of 991 individuals with newly diagnosed T2D were included in the analysis. Autoantibodies were present in 67 subjects (6.8%), thereby being classified as SAID. Among the remaining 924 participants, sex-stratified k-means clustering (k = 4) identified clusters with metabolic profiles consistent with the classical subtypes: mild age-related diabetes (MARD, n = 326), severe insulin-resistant diabetes (SIRD, n = 241), mild obesity-related diabetes (MOD, n = 206), and severe insulin-deficient diabetes (SIDD, n = 151). However, cluster separation was modest, and bootstrap stability was limited (Jaccard 0.555–0.718). In an unconstrained analysis, apart from the autoimmune diabetes group, silhouette optimisation identified three clusters as the most internally optimal structure, corresponding broadly to obesity/insulin-resistant (C1, n = 347), insulin-deficient (C2, n = 186), and age- related (C3, n = 391) phenotypes. Stability was substantially higher for the three-cluster solution (Jaccard 0.799–0.863). Concordance between the Ahlqvist and data-driven models was moderate (ARI = 0.473), with MOD individuals distributed across the other clusters. Conclusions The Ahlqvist clustering architecture could be approximated in this Mediterranean cohort at diagnosis, but internal stability of the five-cluster solution was limited. In this population, a four-cluster structure showed substantially better internal validity. These findings support the feasibility of phenotypic subclassification of T2D., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017- 89827-R and Instituto de Salud Carlos III, Ministry of Health (FIS PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022–2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII). This research was also partially supported by an unrestricted grant from Menarini Group. The sponsor did not have any roles in the study design, collection, analysis, interpretation of data, writing of the report or the decision to submit the article for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort

  • Fernandez-Camins, Berta
  • Vlacho, Bogdan
  • Rojo-López, Marina Idalia
  • Granado-Casas, Minerva
  • Gratacòs, Mònica
  • Ortega-Bravo, Marta
  • Cendros-Massioui, Maria
  • Palmieri, Flavio
  • Perera Lluna, Alexandre
  • Franch-Nadal, Josep
  • Mauricio, Dídac
  • COPERNICAN Research Group, The
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Supplementary Information The online version contains supplementary material available at https://doi.org/10.1186/s12933-026-03198-w., Background: Current diagnostic criteria for type 2 diabetes (T2D) capture disease heterogeneity poorly, and do not reliably predict progression, complications, or treatment response. The phenotypic clustering model proposed by Ahlqvist et al. identified five T2D subtypes using six clinical variables at diagnosis, each associated with distinct metabolic profiles and complication risks. Although this framework has been replicated in several cohorts, evidence in Mediterranean populations is lacking. Methods We conducted a prospective cohort study in Catalonia (Northeast Spain) including adults with newly diagnosed T2D recruited between March 2022 and January 2026. Using baseline data, we evaluated the Ahlqvist clustering approach. Autoantibody-positive individuals were classified as severe autoimmune diabetes (SAID), and sex-stratified k-means clustering (k = 4) was applied to autoantibody-negative participants. Cluster separation and stability were assessed using principal component analysis and silhouette analyses. Results A final total number of 991 individuals with newly diagnosed T2D were included in the analysis. Autoantibodies were present in 67 subjects (6.8%), thereby being classified as SAID. Among the remaining 924 participants, sex-stratified k-means clustering (k = 4) identified clusters with metabolic profiles consistent with the classical subtypes: mild age-related diabetes (MARD, n = 326), severe insulin-resistant diabetes (SIRD, n = 241), mild obesity-related diabetes (MOD, n = 206), and severe insulin-deficient diabetes (SIDD, n = 151). However, cluster separation was modest, and bootstrap stability was limited (Jaccard 0.555–0.718). In an unconstrained analysis, apart from the autoimmune diabetes group, silhouette optimisation identified three clusters as the most internally optimal structure, corresponding broadly to obesity/insulin-resistant (C1, n = 347), insulin-deficient (C2, n = 186), and age- related (C3, n = 391) phenotypes. Stability was substantially higher for the three-cluster solution (Jaccard 0.799–0.863). Concordance between the Ahlqvist and data-driven models was moderate (ARI = 0.473), with MOD individuals distributed across the other clusters. Conclusions The Ahlqvist clustering architecture could be approximated in this Mediterranean cohort at diagnosis, but internal stability of the five-cluster solution was limited. In this population, a four-cluster structure showed substantially better internal validity. These findings support the feasibility of phenotypic subclassification of T2D., This research received financial support from the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) PID2021-122952OB-I00, DPI2017- 89827-R and Instituto de Salud Carlos III, Ministry of Health (FIS PI21/01163). This work has been financed by a PERIS grant from the Primary Care Oriented Research Projects program with the reference number SLT021/21/000030 granted by the Generalitat de Catalunya (2022–2024). CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM; leading group CB15/00071) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), are initiatives of Instituto de Salud Carlos III (ISCIII). This research was also partially supported by an unrestricted grant from Menarini Group. The sponsor did not have any roles in the study design, collection, analysis, interpretation of data, writing of the report or the decision to submit the article for publication., Postprint (published version)